OPTIMER PHARMACEUTICALS INC Increase (Decrease) in Deferred Revenue
OPTIMER PHARMACEUTICALS INC reported Increase (Decrease) in Deferred Revenue of -$335.43 thousand for the 6-month period ending 2013-06-30, per its 10-Q filed 2013-08-07.
Discontinued › Cash Flow › Operating Activities
us-gaap:IncreaseDecreaseInDeferredRevenue · last filed 2013-08-07
- OPTIMER PHARMACEUTICALS INC increase (decrease) in deferred revenue for the quarter ending 2013-06-30 was -$7.41K.
- OPTIMER PHARMACEUTICALS INC increase (decrease) in deferred revenue for the quarter ending 2013-03-31 was -$328.02K.
- OPTIMER PHARMACEUTICALS INC increase (decrease) in deferred revenue for the quarter ending 2012-12-31 was $301.83K.
- OPTIMER PHARMACEUTICALS INC increase (decrease) in deferred revenue for the quarter ending 2012-09-30 was -$90.90K.
- OPTIMER PHARMACEUTICALS INC increase (decrease) in deferred revenue for fiscal 2012 was $456.25K.
| Period end | Increase (Decrease) in Deferred Revenue 3 month | Increase (Decrease) in Deferred Revenue 6 month | Increase (Decrease) in Deferred Revenue 9 month | Increase (Decrease) in Deferred Revenue 12 month |
|---|---|---|---|---|
| 2013-06-30 | -$7.41K derived: 10-Q 6 month − 10-Q 3 month · filed 2013-08-07 | -$335.43K 10-Q · filed 2013-08-07 | -$33.60K derived: sum of 3 quarters · filed 2013-08-07 | -$124.50K derived: sum of 4 quarters · filed 2013-08-07 |
| 2013-03-31 | -$328.02K 10-Q · filed 2013-05-10 | -$26.19K derived: sum of 2 quarters · filed 2013-05-10 | -$117.09K derived: sum of 3 quarters · filed 2013-05-10 | |
| 2012-12-31 | $301.83K derived: 10-K 12 month − 10-Q 9 month · filed 2013-03-18 | $210.93K derived: sum of 2 quarters · filed 2013-03-18 | $456.25K 10-K · filed 2013-03-18 | |
| 2012-09-30 | -$90.90K derived: 10-Q 9 month − 10-Q 6 month · filed 2012-11-02 | $154.42K 10-Q · filed 2012-11-02 | ||
| 2012-06-30 | $245.32K 10-Q · filed 2013-08-07 |